Hinrich Staecker, M.D., Ph.D.
MD: 1991, Albert Einstein College of Medicine
PhD: University of Liege, Liege, Belgium
Internship: General Surgery, Montefiore Medical Center/Albert Einstein College of Medicine
Fellowship: Neuropathology, Albert Einstein College of Medicine
Residency: Otolaryngology, Montefiore Medical Center
Fellowship: Otology/ Neurotology, Harvard Medical School/Massachusetts Eye and Ear Infirmary
Publications: Click here
Hinrich Staecker, MD, PhD trained at Albert Einstein College of Medicine and Massachusetts Eye and Ear infirmary. His clinical practice at the University of Kansas School of Medicine focuses on otology and neurotology, specifically cochlear implantation, auditory brain stem implants and acoustic neuroma surgery. His research projects are aimed at improving the treatment of sensorineural hearing loss using both molecular therapeutics and devices. Current projects include developing drug delivery for inner ear disease and developing gene therapy for the treatment of inner ear disease.
Currently his lab is evaluating the effect of different vector constructs on cochlear and vestibular function and evaluating the efficacy of atoh1 gene transfer for the regeneration of vestibular function. He is the principal investigator in the first in man hair cell regeneration gene therapy trial and multiple trials focusing on inner ear drug delivery. He is a member of the Triological Society, the American Otological Society and the Collegium Oto-Rhino-Laryngologicum.